Atlas Trials

Efficacy and Safety of Activated Recombinant Human Factor VII in Refractory Haemorrhagic Cystitis

Clinical trial NCT01561352 · COMPLETED

Trial details

NCT number
NCT01561352
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Other Haemostasis DisorderHaemorrhagic Cystitis
Start date
2001-09-01
Primary completion
2003-11-01
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.